Key Advances in Endometrial Cancer

January 29, 2021

Kathleen Moore, MD, Stephenson Cancer Center

, David M. O'Malley, MD, The Ohio State University

David M. O'Malley, MD, The Ohio State University

Key opinion leaders provide insight into promising advancements for the management of endometrial cancer, and consider how they have changed practice.

Key Advances in Endometrial Cancer

Kathleen Moore, MD, Stephenson Cancer Center

David M. O'Malley, MD, The Ohio State University

Phase 3 OVAL Trial of VB-111 in Platinum-Resistant Ovarian Cancer Gets Green Light to Continue

FDA Grants Fast Track Status to Immunotherapy GEN-1 in Advanced Ovarian Cancer

Germline Genetic Testing Gap Persists in Ovarian Cancer, More Delimited Panel Composition Needed to Improve Utility